Mice injected with RhoA-deficient BCR-ABL1 cells did not develop leukemia when compared to mice injected with control cells as evidenced by reduced spleen size and total number of blasts in both spleen and bone marrow (Figures 6C, D). The gene discussed is RHOA; the disease is leukemia.